Literature DB >> 35031577

Bone Marrow Transplantation Rescues Monocyte Recruitment Defect and Improves Cystic Fibrosis in Mice.

Zhichao Fan1,2, Elise Pitmon2, Lai Wen1, Jacqueline Miller1, Erik Ehinger1, Rana Herro3, Wei Liu2, Ju Chen2, Zbigniew Mikulski4, Douglas J Conrad5, Alex Marki1, Marco Orecchioni1, Puja Kumari2, Yanfang Peipei Zhu1, Paola M Marcovecchio1, Catherine C Hedrick1, Craig A Hodges6, Vijay A Rathinam2, Kepeng Wang2, Klaus Ley7,8.   

Abstract

Cystic fibrosis (CF) is an inherited life-threatening disease accompanied by repeated lung infections and multiorgan inflammation that affects tens of thousands of people worldwide. The causative gene, cystic fibrosis transmembrane conductance regulator (CFTR), is mutated in CF patients. CFTR functions in epithelial cells have traditionally been thought to cause the disease symptoms. Recent work has shown an additional defect: monocytes from CF patients show a deficiency in integrin activation and adhesion. Because monocytes play critical roles in controlling infections, defective monocyte function may contribute to CF progression. In this study, we demonstrate that monocytes from CFTRΔF508 mice (CF mice) show defective adhesion under flow. Transplanting CF mice with wild-type (WT) bone marrow after sublethal irradiation replaced most (60-80%) CF monocytes with WT monocytes, significantly improved survival, and reduced inflammation. WT/CF mixed bone marrow chimeras directly demonstrated defective CF monocyte recruitment to the bronchoalveolar lavage and the intestinal lamina propria in vivo. WT mice reconstituted with CF bone marrow also show lethality, suggesting that the CF defect in monocytes is not only necessary but also sufficient to cause disease. We also show that monocyte-specific knockout of CFTR retards weight gains and exacerbates dextran sulfate sodium-induced colitis. Our findings show that providing WT monocytes by bone marrow transfer rescues mortality in CF mice, suggesting that similar approaches may mitigate disease in CF patients.
Copyright © 2022 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35031577      PMCID: PMC8855460          DOI: 10.4049/jimmunol.1901171

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  66 in total

Review 1.  Intestinal physiology and pathology in gene-targeted mouse models of cystic fibrosis.

Authors:  B R Grubb; S E Gabriel
Journal:  Am J Physiol       Date:  1997-08

2.  Limited restoration of cystic fibrosis lung epithelium in vivo with adult bone marrow-derived cells.

Authors:  Roberto Loi; Travis Beckett; Kaarin K Goncz; Benjamin T Suratt; Daniel J Weiss
Journal:  Am J Respir Crit Care Med       Date:  2005-09-22       Impact factor: 21.405

3.  Live cell imaging of paxillin in rolling neutrophils by dual-color quantitative dynamic footprinting.

Authors:  Prithu Sundd; Edgar Gutierrez; Brian G Petrich; Mark H Ginsberg; Alex Groisman; Klaus Ley
Journal:  Microcirculation       Date:  2011-07       Impact factor: 2.628

4.  High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection.

Authors:  A Oliver; R Cantón; P Campo; F Baquero; J Blázquez
Journal:  Science       Date:  2000-05-19       Impact factor: 47.728

5.  Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors.

Authors:  Vikas Gupta; Mary Eapen; Ruta Brazauskas; Jeanette Carreras; Mahmoud Aljurf; Robert Peter Gale; Gregory A Hale; Osman Ilhan; Jakob R Passweg; Ollé Ringdén; Mitchell Sabloff; Hubert Schrezenmeier; Gerard Socié; Judith C W Marsh
Journal:  Haematologica       Date:  2010-09-17       Impact factor: 9.941

Review 6.  Protective and pathogenic functions of macrophage subsets.

Authors:  Peter J Murray; Thomas A Wynn
Journal:  Nat Rev Immunol       Date:  2011-10-14       Impact factor: 53.106

7.  Neutrophil-mediated phagocytic host defense defect in myeloid Cftr-inactivated mice.

Authors:  Hang Pong Ng; Yun Zhou; Kejing Song; Craig A Hodges; Mitchell L Drumm; Guoshun Wang
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

Review 8.  Cystic Fibrosis Lung Infections: Polymicrobial, Complex, and Hard to Treat.

Authors:  Laura M Filkins; George A O'Toole
Journal:  PLoS Pathog       Date:  2015-12-31       Impact factor: 6.823

9.  Microfluidics-based side view flow chamber reveals tether-to-sling transition in rolling neutrophils.

Authors:  Alex Marki; Edgar Gutierrez; Zbigniew Mikulski; Alex Groisman; Klaus Ley
Journal:  Sci Rep       Date:  2016-06-30       Impact factor: 4.379

10.  Editing an α-globin enhancer in primary human hematopoietic stem cells as a treatment for β-thalassemia.

Authors:  Sachith Mettananda; Chris A Fisher; Deborah Hay; Mohsin Badat; Lynn Quek; Kevin Clark; Philip Hublitz; Damien Downes; Jon Kerry; Matthew Gosden; Jelena Telenius; Jackie A Sloane-Stanley; Paula Faustino; Andreia Coelho; Jessica Doondeea; Batchimeg Usukhbayar; Paul Sopp; Jacqueline A Sharpe; Jim R Hughes; Paresh Vyas; Richard J Gibbons; Douglas R Higgs
Journal:  Nat Commun       Date:  2017-09-04       Impact factor: 14.919

View more
  3 in total

Review 1.  CFTR and Gastrointestinal Cancers: An Update.

Authors:  Rahul Bhattacharya; Zachary Blankenheim; Patricia M Scott; Robert T Cormier
Journal:  J Pers Med       Date:  2022-05-25

Review 2.  Neutrophil dysfunction in the pathogenesis of cystic fibrosis.

Authors:  Guoshun Wang; William M Nauseef
Journal:  Blood       Date:  2022-04-28       Impact factor: 25.476

Review 3.  Immune Cell Plasticity in Inflammation: Insights into Description and Regulation of Immune Cell Phenotypes.

Authors:  Andreas Margraf; Mauro Perretti
Journal:  Cells       Date:  2022-06-02       Impact factor: 7.666

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.